Impact of endocrine disruptors in cosmetics on reproductive function in males and females

review OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-24 · read from full text

This paper reviews endocrine disrupting chemicals (EDCs) used in cosmetics and personal care products, focusing on their potential adverse effects on reproductive function in males and females, and discusses risk assessment for chemical classes such as parabens, phthalates, and UV filters. It concludes that EDC exposure may negatively affect reproductive systems, citing reproductive problems including polycystic ovarian syndrome, hypospadias, cryptorchidism, ovarian cancer, endometriosis, and poor sperm quality. The authors also explicitly note that little research has been conducted on the health effects of cosmetic EDCs, which limits confidence in the current evidence base. Relevance to endometriosis: the paper specifically lists endometriosis among the reproductive disorders potentially caused by EDCs in cosmetics and personal care products, though the work is a general review of cosmetic EDC reproductive risks.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The cosmetic and personal care product (PCP) industries have bloomed in the last ten years. Many new brand names have established themselves with various lucrative advertisements, luring youths into their primary customers. Many chemicals infused into daily day-night creams or shampoo conditioners have been established as Endocrine Disrupting Chemicals (EDC). The unseen side of the coin has been flipped in this article in an attempt to relate the rising infertility issue with these products. The study aims to explore the potential adverse effects and risk assessment of the EDCs of cosmetics and personal care products, which highlights a thorough review to indicate whether chemicals such as parabens, phthalates, or UV filters are safe for reproductive physiology. EDCs may cause severe negative impacts on the reproductive systems of both males and females which include reproductive problems such as polycystic ovarian syndrome, hypospadias, cryptorchidism, ovarian cancer, endometriosis, and poor sperm quality. Despite the widespread usage and purchase of cosmetic products in the present world, little research has been conducted on the possible effects of cosmetic EDCs on health. Consequently, further in-depth research needs to be performed in this field for a better understanding of the reproductive risks caused by cosmetic EDCs.
Full text 1,842 characters · extracted from oa-doi-fallback · click to expand
Abstract The cosmetic and personal care product (PCP) industries have bloomed in the last ten years. Many new brand names have established themselves with various lucrative advertisements, luring youths into their primary customers. Many chemicals infused into daily day-night creams or shampoo conditioners have been established as Endocrine Disrupting Chemicals (EDC). The unseen side of the coin has been flipped in this article in an attempt to relate the rising infertility issue with these products. The study aims to explore the potential adverse effects and risk assessment of the EDCs of cosmetics and personal care products, which highlights a thorough review to indicate whether chemicals such as parabens, phthalates, or UV filters are safe for reproductive physiology. EDCs may cause severe negative impacts on the reproductive systems of both males and females which include reproductive problems such as polycystic ovarian syndrome, hypospadias, cryptorchidism, ovarian cancer, endometriosis, and poor sperm quality. Despite the widespread usage and purchase of cosmetic products in the present world, little research has been conducted on the possible effects of cosmetic EDCs on health. Consequently, further in-depth research needs to be performed in this field for a better understanding of the reproductive risks caused by cosmetic EDCs. Author’s contributions Ahmed Lasaneya was responsible for designing the study and composing and gathering data. Queen Saikia contributed to proofreading. Sagarika Dutta assisted in editing and Prof Jogen. Chandra. Kalita provided supervision and overall guidance for the research. Disclosure statement No potential conflict of interest was reported by the author(s). Data availability statement No data will be available because this study incorporates all evaluated dataset findings.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics Cosmetics

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-07-07T06:07:59.301721+00:00
pubmed
last seen: 2026-07-07T06:04:45.416270+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine